Dx Deals: Collaboration Takes Psoriasis Testing to New Level
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
In a surprise move, the e-retail giant announced it will close down its Amazon Care Primary Health Services for employees at the end of 2022.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.
Some of the lab industry’s biggest players are teaming up to develop new monkeypox diagnostics in response to the current outbreak.
A hostile government policy has done little to slow consolidation of independent medical practices and hospitals.